Patients in France positive for chronic hepatitis B virus infection had increased mortality due to chronic liver disease, hepatocellular carcinoma or non-Hodgkin lymphoma compared with the general population, according to data published in the Journal of Hepatology.
“In France, about 3 million people have been in contact with HBV, and 280,800 have chronic HCV infection,” the researchers wrote. “Hepatitis B-related mortality in developed countries is not well-known.
The aim of this study was first to evaluate the risk of mortality in a population-based cohort of people with chronic HBV infection compared with the general population, and second to identify predictors of all-cause mortality and HBV
Share This Page